Tributylmethylammonium

Tributylmethylammonium

SCHEMBL1618259

CCCC[N+](C)(CCCC)CCCC.CS(=O)(=O)[O-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of Tributylmethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 3/20 0.40
SLC22A1 O15245 2/20 0.39
DNM1 Q05193 7/20 0.39
LSS P48449 1/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
GRK2 P25098 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
RECQL P46063 2/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
EPHX2 P34913 1/20 0.35
BLM P54132 1/20 0.35
HTT P42858 1/20 0.35
SLC22A2 O15244 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tributylmethylammonium SCHEMBL1627725 0.92 BBOX1 (0.41) BBOX1SLC22A1DNM1LSSMEN1
SCHEMBL10968148 0.91 LSS (0.50) SLC22A1DNM1LSSKMT2ATSHR
SCHEMBL330855 0.91 LSS (0.50) SLC22A1DNM1LSSKMT2ATSHR
SCHEMBL1815762 0.91 LSS (0.50) SLC22A1DNM1LSSKMT2ATSHR
SCHEMBL330762 0.91 LSS (0.50) SLC22A1DNM1LSSKMT2ATSHR
SCHEMBL330474 0.91 LSS (0.50) SLC22A1DNM1LSSKMT2ATSHR
Tributylmethylammonium SCHEMBL1337147 0.90 BBOX1 (0.40) BBOX1SLC22A1DNM1LSSMEN1
Tributylmethylammonium SCHEMBL3392205 0.88 LMNA (0.39) BBOX1SLC22A1DNM1LSSMEN1
Tributylmethylammonium SCHEMBL268725 0.88 MEN1 (0.39) BBOX1SLC22A1DNM1LSSMEN1
SCHEMBL23003058 0.85 BBOX1 (0.56) BBOX1SLC22A1DNM1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US claimed
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES ENTEGRIS INC (US) 2026-01-15 US disclosed
US-20230279560-A1 CYCLIC COMPOUNDS AS AROMA CHEMICALS BASF SE (DE) 2023-09-07 US disclosed
EP-1848790-B1 SEMICONDUCTOR CLEANING ADVANCED PROCESS TECHNOLOGIES LLC (US) 2015-04-08 EP disclosed
US-20110187010-A1 SEMICONDUCTOR CLEANING USING SUPERACIDS SMALL ROBERT J 2011-08-04 US disclosed
US-7923424-B2 Semiconductor cleaning using superacids ADVANCED PROCESS TECHNOLOGIES, LLC (US) 2011-04-12 US disclosed
US-7659430-B2 Method for separating hydrogen chloride and phosgene BASF AKTIENGESELLSCHAFT (DE) 2010-02-09 US disclosed
EP-1789160-B1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF SE (DE) 2009-11-18 EP disclosed
US-20070293707-A1 Method for Separating Hydrogen Chloride and Phosgene BASF AKTIENGESELLSCHAFT (DE) 2007-12-20 US disclosed
EP-1789160-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2007-05-30 EP disclosed
US-20060183248-A1 Semiconductor cleaning using superacids ADVANCED PROCESS TECHNOLOGIES, LLC 2006-08-17 US disclosed
US-20060183654-A1 Semiconductor cleaning using ionic liquids ADVANCED PROCESS TECHNOLOGIES, LLC 2006-08-17 US disclosed
WO-2006029788-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293707-A1 Method for Separating Hydrogen Chloride and Phosgene PSPH, SLC9B2, HVCN1 BBOX1 3919/4885SLC22A1 776/4885DNM1 4070/4885
US-20260015560-A1 COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES TET2, ASIC1, PIEZO1 BBOX1 2686/4885SLC22A1 2747/4885DNM1 2538/4885
US-20230279560-A1 CYCLIC COMPOUNDS AS AROMA CHEMICALS C1S, VDAC2, VDAC3 BBOX1 907/4885SLC22A1 3637/4885DNM1 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.